ARTICULOS MAYO 2023. 06:30 HRS: CARDIOLOGÍA.

FECHA ARTÍCULO DOI

02 DE Natriuretic Peptides: It Is Time for doi: 10.3390/ijms24065131

MAYO Guided Therapeutic Strategies Based
on Their Molecular Mechanism.

03 DE Neprilysin Inhibitors in Heart Failure doi: 10.1016/j.jacbts.2022.05.010

MAYO

04 DE Cardiorenal benefits of finerenone: doi: 10.1080/07853890.2023.2171110

MAYO protecting kidney and heart

08 DE The history and mystery of doi: 10.3389/fcvm.2023.1102521

MAYO sacubitril/valsartan: From clinical trial
to the real world

09 DE Early Rhythm Control Therapy in doi: 10.1161/CIRCULATIONAHA.121.056323

MAYO Patients With Atrial Fibrillation and
Heart Failure

10 DE Management of Blood Pressure in doi: 10.7326/M21-0834

MAYO Patients With Chronic Kidney Disease
Not Receiving Dialysis: Synopsis of the
2021 KDIGO Clinical Practice Guideline

11 DE Heart failure in the elderly doi: 10.11909/j.issn.1671-5411.2021.03.009

MAYO

12 DE The Association between Coffee Intake doi: 10.1161/CIRCHEARTFAILURE.119.006799

MAYO and Incident Heart Failure Risk – A
Machine Learning Analysis of the
Framingham Heart, Atherosclerosis Risk
in Communities study, and
Cardiovascular Health Studies

15 DE Pulmonary Arterial Hypertension DOI: 10.1056/NEJMra2000348

MAYO

16 DE Sepsis-Induced Cardiomyopathy: a https://doi.org/10.1007/s11886-020-01277-2

MAYO Comprehensive Review

17 DE Therapeutic potential of colchicine in https://doi.org/10.1038/s41401-021-00835-w

MAYO cardiovascular medicine:

a pharmacological review

18 DE Congestion in heart failure: a https://doi.org/10.1038/ s41569-020-0379-7

MAYO contemporary look at physiology,
diagnosis and treatment.

19 DE Combining loop with thiazide diuretics https://doi.org/10.1093/eurheartj/ehac689

MAYO for decompensated heart failure: the
CLOROTIC trial

22 DE Acetazolamide in Acute DOI: 10.1056/NEJMoa2203094

MAYO Decompensated Heart Failure with
 ARTICULOS MAYO 2023. 06:30 HRS: CARDIOLOGÍA.

Volume Overload

23 DE Management of patients with heart http://dx.doi.org/10.1136/heartjnl-2022-321097

MAYO failure and preserved ejection fraction

24 DE Blood Pressure Control in Elderly doi: 10.5049/EBP.2022.20.2.57

MAYO Chronic Kidney Disease Patients

25 DE Bedtime hypertension treatment https://doi.org/10.1093/eurheartj/ehz754

MAYO improves cardiovascular risk reduction:
the Hygia Chronotherapy Trial

26 DE Diagnosis and treatment of cardiac doi: 10.1093/eurheartj/ehab072

MAYO amyloidosis: a position statement of
the ESC Working Group on Myocardial
and Pericardial Diseases

29 DE Heart failure with reduced ejection https://doi.org/10.1093/eurheartjsupp/suac114

MAYO fraction

and the intersection of cardio-renal-

metabolic

medicine

30 DE Cardiorenal Syndrome in the Hospital. doi: https://doi.org/10.2215/CJN.0000000000000064

MAYO

31 DE Management of Heart Failure in DOI: https://doi.org/10.15420/ecr.2021.33

MAYO Patients with Chronic Kidney Disease